Aveanna Healthcare Holdings Inc. (AVAH)
USD 4.53
(-0.66%)
USD 4.53
(-0.66%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.27 Billion USD | -3.81% |
| 2022 | 1.32 Billion USD | 4.38% |
| 2021 | 1.27 Billion USD | 5.6% |
| 2020 | 1.2 Billion USD | 13.69% |
| 2019 | 1.05 Billion USD | 12.27% |
| 2018 | 943.03 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.27 Billion USD | -0.1% |
| 2024 Q2 | 1.27 Billion USD | -0.09% |
| 2023 Q4 | 1.27 Billion USD | -3.32% |
| 2023 Q1 | 1.32 Billion USD | -0.3% |
| 2023 FY | 1.27 Billion USD | -3.81% |
| 2023 Q2 | 1.32 Billion USD | -0.1% |
| 2023 Q3 | 1.32 Billion USD | -0.11% |
| 2022 Q3 | 1.32 Billion USD | 7.08% |
| 2022 Q2 | 1.23 Billion USD | -2.34% |
| 2022 FY | 1.32 Billion USD | 4.38% |
| 2022 Q1 | 1.26 Billion USD | -0.17% |
| 2022 Q4 | 1.32 Billion USD | -0.02% |
| 2021 FY | 1.27 Billion USD | 5.6% |
| 2021 Q4 | 1.27 Billion USD | 46.15% |
| 2021 Q3 | 869.77 Million USD | -0.45% |
| 2021 Q2 | 873.74 Million USD | -27.33% |
| 2021 Q1 | 1.2 Billion USD | -0.12% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 1.2 Billion USD | 13.69% |
| 2020 Q4 | 1.2 Billion USD | 0.0% |
| 2019 FY | 1.05 Billion USD | 12.27% |
| 2018 FY | 943.03 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 4.931% |
| Addus HomeCare Corporation | 124.13 Million USD | -928.213% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -1736.383% |
| Amedisys, Inc. | 346.76 Million USD | -268.074% |
| American Oncology Network, Inc. | 120.44 Million USD | -959.697% |
| Astrana Health, Inc. | 296.26 Million USD | -330.816% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | -1096.981% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -13650.748% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -47828.689% |
| COMPASS Pathways plc | 28.75 Million USD | -4338.366% |
| DocGo Inc. | 15.16 Million USD | -8318.07% |
| The Ensign Group, Inc. | 1.78 Billion USD | 28.489% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -11260.401% |
| InnovAge Holding Corp. | 100.49 Million USD | -1170.042% |
| Assure Holdings Corp. | 505 Thousand USD | -252640.792% |
| The Joint Corp. | 2 Million USD | -63717.05% |
| LifeStance Health Group, Inc. | 280.28 Million USD | -355.373% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -334512.087% |
| ModivCare Inc. | 983.75 Million USD | -29.741% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -1072644.77% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -72476.488% |
| Option Care Health, Inc. | 1.05 Billion USD | -20.791% |
| P3 Health Partners Inc. | 108.31 Million USD | -1078.317% |
| P3 Health Partners Inc. | 108.31 Million USD | -1078.317% |
| The Pennant Group, Inc. | 312.51 Million USD | -308.416% |
| Surgery Partners, Inc. | 2.03 Billion USD | 37.237% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -1369.999% |
| The Oncology Institute, Inc. | 86.82 Million USD | -1369.999% |